Our mission
- Light Chain Bioscience partners with Edesa
- Collaborations with Discoveric Group
- Edesa Biotech Announces Positive Phase 2 Data of Its Monoclonal Antibody in Hospitalized COVID-19 Patients
- First Patient dosed with NILK-2401 in Phase I clinical trial
- First patient dosed with NILK-2301 in Phase I clinical trial
- LegoChem Biosciences, Light Chain Bioscience & Iksuda
- Milestone reached in the clinical development of TG-1801 (NI-1701)
- Research collaboration with LamKap Bio
- Successful Discovery for TAKEDA
